Product Details
| Product Name:
TA-1801 |
CAS No.:
88352-44-7 |
| Supply Ability:
10g |
Release date:
2025/07/16 |
Product Introduction
Bioactivity
| Name | TA-1801 |
| Description | TA-1801 is an agent of hypolipidemic. |
| In vitro | in vitro, TA-1801 inhibits platelet aggregation . |
| In vivo | Administered at a 0.05% dosage in the diet of normal rats, TA-1801 decreases serum cholesterol and triglyceride levels by 23% and 35%, respectively. Notably, its effectiveness increases approximately tenfold in hereditary hyperlipidemic rats (THLR/1) compared to normal rats. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | TA1801 | TA-1801 | TA 1801 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:103300-77-2
$488.00 / 2mg
-
CAS:885060-08-2
$747.00 / 50mg
-
CAS:104756-72-1
$2500.00 / 100mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$56.00/1mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-10-25 |
|
|
$0.00/25kg |
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-03-09 |
|
|
$2500.00/100mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-07-27 |
United States